期刊文献+

缬沙坦分散片的研制 被引量:1

Study on preparation of valsartan dispersible tablets
下载PDF
导出
摘要 目的制备缬沙坦分散片并对其相关性能进行考察。方法采用L9(34)正交试验设计法,以综合评分法筛选出最佳处方;采用紫外分光光度法测定产品45min的累积溶出度。结果优化后的处方制得的分散片外观光洁,在1min内完全崩解,20min溶出度可达95%以上,各项指标均符合药典规定。结论优化所得处方合理,制备工艺简单,产品性能良好。 OBJECTIVE To prepare valsartan dispersible tablets and investigate its related properties. METHODS The formulation was optimized by using L9 (3^4) orthogonal design which took the appearance,disintegration times and the dissolution rate of the tablets as indices. The dissolution rate of 45 min was determined by ultraviolet spectrophotometry. RESULTS The optimized tablets are fine in appearance,disintegrated within 1 min and the dissolution rate is more than 95% at 20 min. CONCLUSION The optimized formulation is rational and preparation craft is simple The tablet related properties are good.
出处 《齐鲁药事》 2008年第12期742-744,共3页 qilu pharmaceutical affairs
关键词 缬沙坦 分散片 处方筛选 正交设计 Valsartan dispersible tablets formula optimization orthogonal design
  • 相关文献

参考文献4

二级参考文献40

  • 1王孟琴,田淑媛.钾镁分散片的研制及临床观察[J].西北药学杂志,1994,9(4):175-176. 被引量:2
  • 2罗云,马红斌,蔡鸿生.扑热息痛分散片制备及质量控制[J].现代应用药学,1996,13(3):34-35. 被引量:4
  • 3王卓,韩丽梅,张晓青,邓英杰,张艳华,王越.利用均匀设计筛选阿司匹林分散片处方[J].沈阳药科大学学报,1996,13(4):235-239. 被引量:18
  • 4王受益,戴瑞鸿,金椿,罗海明,陈曙霞,陈美芳,徐济民,郑慧君,荣烨之,赵美华,胡婉英,徐雅民.麝香保心丸治疗冠心病心绞痛的临床观察[J].中国中西医结合杂志,1996,16(12):717-720. 被引量:96
  • 5Guidelines Subxommittee.1999 WorldHealth Organizatiou-International Society of Hypertension Guidelines for the Mana-gementof Hyertension. J Hypertersion.1999;17:151-183.
  • 6Weber MA.Clinical experience with the angiotensin Ⅱ receptor antagonistlosartan:a preliminary report. Am J Hypertens.1992;5:247S-251S.
  • 7De Gasparo M,Siragy HM.The AT2 recepor:fact,fancy and fantasy. RegulatoryPeptides.1999;81:11-24.
  • 8Criscone L,Gradley WA,Buehlmayerp,et al.Valsartan:preclinical and clinical profileof an antihypertensive angiotensin Ⅱ antagonist. Cardiovasc Drug Rev.1995;13:230-250.
  • 9Markham A,Goa KL.Valsartan.A review of its pharmacology and Therapeutic use inessential hypertension. Drugs.1997;54:299-311.
  • 10Griscione L,De Gasparo M,Buhlmayer P,et al.Pharmacological profile ofvalsartan:apotent,orally active,nonpeptide antagonist of the angiotensin Ⅱ AT1-receptorsubtype. Br J pharmacot.1993;110:761-771.

共引文献126

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部